Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: A risk factor for hospitalization and mortality in women

Respiratory Medicine

Volumn 92, Issue 1, 1998, Pages 50-56

  Strom K ^a,b  

^a Swedish Society of Chest Medicine   (Sweden)

^b BLEKINGE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; FEMALE; HEALTH CARE NEED; HOSPITALIZATION; HUMAN; HYPOXEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

EID: 0031934561     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90032-4     Document Type: Article

References (25)

1. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in chronic obstructive lung disease. Ann Intern Med 1980; 93: 391-398.
2. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; i: 681-686.
3. McSweeney AJ, Grant I, Heaton RK, Adams KM, Timms RM. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med 1982; 142: 473-478.
4. Derenne J-P, Fleury B, Pariente R. Acute respiratory failure of chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 13: 1006-1033 (review).
5. Petty TL, Neff TA, Creagh E et al. Outpatient oxygen therapy in chronic obstructive pulmonary disease. Arch Intern Med 1979; 139: 28-32.
6. Ström K, Boe J. A national register for long-term oxygen therapy in chronic hypoxia: preliminary results. Eur Respir J 1988; 1: 952-958.
7. Postma DS, Steenhuis EJ, vd Weele LT, Sluiter HJ. Severe chronic airflow obstruction: can corticosteroids slow down obstruction? Eur J Respir Dis 1985; 67: 56-64.
8. Postma DS, Peters I, Steenhuis EJ, Sluiter HJ. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? Eur Respir J 1988; 1: 22-26.
9. Ström K. Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. Am Rev Respir Dis 1993; 147: 585-591.
10. Dompeling E, v Schayck C, Grunsven PM et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. Ann Intern Med 1993; 118: 770-778.
11. Esposito AE, Poirier WJ, Clark EA. The cardiac glycoside digoxin disrupts host defense in experimental pneumococcal pneumonia by impairing neutrophil mobilization. Am Rev Respir Dis 1989; 140: 1590-1594.
12. 2-agonists and methylxanthines on neutrophil function in vitro. Eur Respir J 1994; 7: 1560-1566.
13. Sakuma T, Okaniwa G, Nakada T, Nishimura T, Fujimura S, Matthay MA. Alveolar fluid clearance in the resected human lung. Am J Respir Crit Care Med 1994; 150: 305-310.
14. Nelson S, Summer WR, Jakob GJ. Aminophylline-induced suppression of pulmonary antibacterial defences. Am Rev Respir Dis 1985; 131: 923-927.
15. O'Neill SJ, Siter DS, Klass DJ, Taraska VA, Kepson W, Mitenko PA. The pulmonary disposition of theophylline and its influence on human alveolar macrophage bacterial function. Am Rev Respir Dis 1986; 134: 1225-1228.
16. World Health Organization. Handbook for reporting results of cancer treatment. WHO offset publication no 48. Geneva: WHO, 1979.
17. Ström K, Boe J, The Swedish Society of Chest Medicine. Quality assessment and predictors of survival in long-term oxygen therapy. Eur Respir J 1991; 4: 50-58.
18. Gustavsson E. Quest: A Data Programme for Statistical and Epidemiological Data Analysis. University of Umeå, 1991.
19. Peto R, Pike MC, Armitage P, Breslow NE et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1-39.
20. Miettinen OSA. Estimatability and estimation in case-reference studies. Am J Epidemiol 1976; 103: 226-235.
21. Lech JA, Dulberg C, Kellie S, Pattee E, Gay J. Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis 1990; 141: 68-71.
22. Decramer M, Brock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1958-1964.
23. Skwarski K, MacNee W, Wraith PK, Sliwinski P, Zielinski J. Predictors of survival in patients with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Chest 1991; 100: 1522-1527.
24. Dubois P, Jamart J, Machiels J, Smeets F, Lulling J. Prognosis of severely hypoxemic patients receiving long-term oxygen therapy. Chest 1994; 105: 469-474.
25. Ström K, The Swedish Society of Chest Medicine. Oral steroid medication and hospital care in patients with chronic obstructive pulmonary disease receiving long-term oxygen therapy. Hygiea 1994; 130: 227 (in Swedish).